Literature DB >> 26045095

Risk of Atherosclerosis in Patients with Ataxia Telangiectasia.

Itana Gomes Alves Andrade1, Beatriz Tavares Costa-Carvalho, Rosangela da Silva, Sonia Hix, Cristiane Kochi, Fabíola Isabel Suano-Souza, Roseli Oselka Saccardo Sarni.   

Abstract

BACKGROUND AND AIMS: Evaluate the nutritional status, plasma concentration of vitamin E and markers of cardiovascular risk in ataxia telangiectasia (AT) patients.
METHODS: Cross-sectional study with 13 patients with AT and 22 healthy controls, evaluating the following factors: nutritional status, food intake, lipid profile, plasma concentration of vitamin E, malondialdehyde and high sensitivity C-reactive protein, linking them with atherosclerosis risk in AT patients.
RESULTS: Average age was 14.6 in the AT group, 30.8% were malnourished and 23.1% had stunting. A greater impairment of lean body mass was found in these patients. Concentrations of triglycerides (TG), total cholesterol (CT), LDL-c, non-HDL cholesterol (NHDL-c) were significantly higher in patients and HDL-c, lower. Vitamin E/total lipids and vitamin E/TG ratios were lower in the AT group, and significant inverse correlation between these ratios and NHDL-c, CT/HDL-c, and LDL-c/HDL-c, log TG/HDL-c was observed in the AT group. Alanine aminotransferase correlated directly and significantly with NHDL-c, CT/HDL-c and LDL-c/HDL-c, in patients.
CONCLUSION: The alterations of lipid metabolism biomarkers suggestive of atherosclerotic risk of male AT patients coupled with lower vitamin E/total lipids ratio and low lean body mass may complicate the clinical course of the disease and emphasizes the importance of multidisciplinary care, routine monitoring of cardiovascular biomarkers and appropriate nutritional guidance. 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26045095     DOI: 10.1159/000430790

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  7 in total

Review 1.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

2.  Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients?

Authors:  Talita Lemos Paulino; Marina Neto Rafael; Sonia Hix; David Carlos Shigueoka; Sergio Aron Ajzen; Cristiane Kochi; Fabíola Isabel Suano-Souza; Rosangela da Silva; Beatriz T Costa-Carvalho; Roseli O S Sarni
Journal:  Orphanet J Rare Dis       Date:  2017-08-04       Impact factor: 4.123

3.  The Association between the Lipids Levels in Blood and Risk of Age-Related Macular Degeneration.

Authors:  Yafeng Wang; Mingxu Wang; Xiaoqing Zhang; Qianyu Zhang; Jing Nie; Ming Zhang; Xiaohong Liu; Le Ma
Journal:  Nutrients       Date:  2016-10-22       Impact factor: 5.717

4.  Selenium levels and glutathione peroxidase activity in patients with ataxia-telangiectasia: association with oxidative stress and lipid status biomarkers.

Authors:  Itana Gomes Alves Andrade; Fabíola Isabel Suano-Souza; Fernando Luiz Affonso Fonseca; Carolina Sanchez Aranda Lago; Roseli Oselka Saccardo Sarni
Journal:  Orphanet J Rare Dis       Date:  2021-02-12       Impact factor: 4.123

5.  Deficiency of ataxia-telangiectasia mutated kinase attenuates Western-type diet-induced cardiac dysfunction in female mice.

Authors:  Mary C Wingard; Suman Dalal; Paige L Shook; Paulina Ramirez; Muhammad U Raza; Patrick Johnson; Barbara A Connelly; Douglas P Thewke; Mahipal Singh; Krishna Singh
Journal:  Physiol Rep       Date:  2022-09

6.  Diabetes in Patients With Ataxia Telangiectasia: A National Cohort Study.

Authors:  Helena Donath; Ursula Hess; Matthias Kieslich; Marius Theis; Ute Ohlenschläger; Ralf Schubert; Sandra Woelke; Stefan Zielen
Journal:  Front Pediatr       Date:  2020-07-09       Impact factor: 3.418

7.  Progressive Liver Disease in Patients With Ataxia Telangiectasia.

Authors:  Helena Donath; Sandra Woelke; Marius Theis; Ursula Heß; Viola Knop; Eva Herrmann; Dorothea Krauskopf; Matthias Kieslich; Ralf Schubert; Stefan Zielen
Journal:  Front Pediatr       Date:  2019-11-07       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.